These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6958509)
1. Effects of reporting lags on interim inferences from clinical trials. Gelman R Experientia Suppl; 1982; 41():175-86. PubMed ID: 6958509 [No Abstract] [Full Text] [Related]
2. The Scandinavian clinical trials. Nissen-Meyer R Experientia Suppl; 1982; 41():571-9. PubMed ID: 6958539 [No Abstract] [Full Text] [Related]
3. Fads and fashions of early breast cancer clinical trials in the United States over the past decade (1971-1981). Gelman R Experientia Suppl; 1982; 41():520-41. PubMed ID: 6958535 [No Abstract] [Full Text] [Related]
4. An overview of the breast protocols of NSAPB. Rockette HE; Redmond CK; Fisher B Experientia Suppl; 1982; 41():542-50. PubMed ID: 6754429 [No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy for breast cancer: an overview of NSABP findings. Fisher B; Redmond C; Elias EG; Evans J; Foster R; Jochimsen P; Lawrence W; Lerner H; LiCalzi N; Margolese R; Poisson R; Sachs S; Shibata H; Sutherland C; Wallack M Int Adv Surg Oncol; 1982; 5():65-90. PubMed ID: 7047408 [No Abstract] [Full Text] [Related]
6. Future prospectives in the treatment of breast cancer. Henney JE; DeVita VT Semin Oncol; 1978 Dec; 5(4):465-8. PubMed ID: 366758 [No Abstract] [Full Text] [Related]
7. Performing serial testing of treatment effects. Fleming TR; Green SJ; Harrington DP Experientia Suppl; 1982; 41():469-84. PubMed ID: 6958531 [No Abstract] [Full Text] [Related]
8. Clinical trial design in metastatic breast cancer: a commentary. Levine M Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523 [TBL] [Abstract][Full Text] [Related]
9. Clinical trials in West Germany: adjuvant therapy for breast cancer patients. Bastert GB Experientia Suppl; 1982; 41():618-29. PubMed ID: 6291981 [No Abstract] [Full Text] [Related]
10. Breast cancer trials--a new initiative. Br Med J (Clin Res Ed); 1981 Feb; 282(6263):562-4. PubMed ID: 6780125 [No Abstract] [Full Text] [Related]
11. Experiences and results of breast cancer trials over the past 20 years at the Johannesburg Hospitals. de Moor NG S Afr J Surg; 1982 Sep; 20(3):215-20. PubMed ID: 6817424 [No Abstract] [Full Text] [Related]
12. Breast cancer trials--a new initiative. Br Med J; 1980 Dec; 281(6254):1565-6. PubMed ID: 7437881 [No Abstract] [Full Text] [Related]
13. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial. Heuson JC; Sylvester R; Engelsman E Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920 [No Abstract] [Full Text] [Related]
14. On choosing the number of interim analyses in clinical trials. McPherson K Experientia Suppl; 1982; 41():454-68. PubMed ID: 6958530 [No Abstract] [Full Text] [Related]
15. Treatment evaluation in active control studies. Fleming TR Cancer Treat Rep; 1987 Nov; 71(11):1061-5. PubMed ID: 3119201 [No Abstract] [Full Text] [Related]
17. Adjuvant therapy for breast cancer. Margolese RG Can J Surg; 1981 May; 24(3):293-4, 299. PubMed ID: 7016288 [TBL] [Abstract][Full Text] [Related]
18. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer. Cavalli F; Alberto P; Jungi F; Brunner K; Martz G Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922 [No Abstract] [Full Text] [Related]
19. Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment. Tormey DC; Gelman RS Cancer Clin Trials; 1981; 4(4):355-62. PubMed ID: 7032730 [TBL] [Abstract][Full Text] [Related]